Literature DB >> 8558127

Gene organization in the UL region and inverted repeats of the canine herpesvirus genome.

M Rémond1, P Sheldrick, F Lebreton, P Nardeux, T Foulon.   

Abstract

Restriction mapping and the determination of scattered nucleotide sequences have permitted a description of the global structure and evolutionary affinities of the canine herpesvirus (CHV) genome. The global structure closely resembles that of the totally sequenced genomes of varicella-zoster virus and equine herpesvirus 1 (EHV-1) in having a 37 bp inverted repeat flanking a long unique region (UL) of approximately 100,000 bp, and a 10,100-10,700 bp inverted repeat flanking a short unique region (U8) of roughly 7,400-8,600 bp. On the basis of the sequences obtained, 35 homologues to previously identified herpesvirus gene products were found in UL and the major inverted repeat, and the level of the similarities indicated that CHV belongs to the genus Varicellovirus. Within the genus, CHV appears to be most closely related to EHV-1, pseudorabies virus and feline herpesvirus. Surprisingly, genes for both subunits of the viral ribonucleotide reductase were found to be missing from their equivalent place in other herpesvirus genomes. Either they have been translocated to another position in the CHV genome or, we think more likely, they have been lost.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8558127     DOI: 10.1099/0022-1317-77-1-37

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  The U(L)3 protein of herpes simplex virus 1 is translated predominantly from the second in-frame methionine codon and is subject to at least two posttranslational modifications.

Authors:  N S Markovitz; F Filatov; B Roizman
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Nucleotide sequence of glycoprotein genes B, C, D, G, H and I, the thymidine kinase and protein kinase genes and gene homologue UL24 of an Australian isolate of canine herpesvirus.

Authors:  Gerhard Herbert Reubel; Jenny Pekin; Kyleen Webb-Wagg; Christopher Miles Hardy
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

3.  Sequence and function of canine herpesvirus alpha-transinducing factor and its interaction with an immediate early promoter.

Authors:  Scott G Tyack; Michael J Studdert; Michael A Johnson
Journal:  Virus Genes       Date:  2006-12       Impact factor: 2.332

4.  Sequencing of a 5.5-kb DNA fragment and identification of a gene coding for a subunit of the helicase/primase complex of avian laryngotracheitis virus (ILTV).

Authors:  Q Huang; Y Mat-Arip; P Guo
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

5.  Site-directed mutagenesis of the virion host shutoff gene (UL41) of herpes simplex virus (HSV): analysis of functional differences between HSV type 1 (HSV-1) and HSV-2 alleles.

Authors:  D N Everly; G S Read
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

6.  The equine herpesvirus 1 IR6 protein that colocalizes with nuclear lamins is involved in nucleocapsid egress and migrates from cell to cell independently of virus infection.

Authors:  N Osterrieder; A Neubauer; C Brandmüller; O R Kaaden; D J O'Callaghan
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

7.  First molecular detection of canine herpesvirus 1 (CaHV-1) in the Eastern Brazilian Amazon.

Authors:  Marcela Dos Santos Castro; Maridelzira Betania Moraes David; Evonnildo Costa Gonçalves; Andrei Santos Siqueira; Rodrigo Rodrigues Virgulino; Delia Cristina Figueira Aguiar
Journal:  J Vet Sci       Date:  2021-12-16       Impact factor: 1.672

8.  Genome Sequence of Canine Herpesvirus.

Authors:  Konstantinos V Papageorgiou; Nicolás M Suárez; Gavin S Wilkie; Michael McDonald; Elizabeth M Graham; Andrew J Davison
Journal:  PLoS One       Date:  2016-05-23       Impact factor: 3.240

Review 9.  Canine adenoviruses and herpesvirus.

Authors:  Nicola Decaro; Vito Martella; Canio Buonavoglia
Journal:  Vet Clin North Am Small Anim Pract       Date:  2008-07       Impact factor: 2.093

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.